first entered the Irish market in 2008 with just 15 products and a commitment to provide Irish retail and hospital pharmacists with long-term sustainable value across a broad product portfolio and outstanding customer service. This commitment based on a partnership approach with pharmacists has helped Actavis to grow to be a leading generic supplier with a portfolio of over 100 products (250+ skus) across a range of therapeutic areas. Actavis has been one of the fastest growing generic companies on the Irish market for some time with double digit growth in the past 12 months; this reflects a 19% generics market share (IMS Health, July 2016).
Actavis Your Preferred Partner.
Actavis is pleased to announce the launch of Linezolid.For full prescribing information please see the Products section